AMGN
Amgen Inc
379.80$
+0.9%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +8.0% | +6.1% | -0.6% | +3.9% | -1.6% | +8.8% | +2.2% | +1.3% | +7.1% | +18.6% | +9.9% | |
| – | -4.4% | -1.5% | -2.2% | +0.8% | +6.2% | +41.4% | +4.8% | -0.7% | +31.9% | +52.1% | -16.6% | |
| – | +11.5% | +8.0% | -0.3% | +4.6% | -3.3% | +1.4% | +1.3% | +2.0% | -0.9% | +4.2% | +26.5% | |
| – | -5.3% | -5.7% | -7.2% | +4.9% | +10.1% | +2.2% | +50.3% | -29.9% | +7.9% | +24.7% | +16.9% | |
| – | -4.0% | +2.7% | -8.2% | +9.6% | -6.4% | +9.3% | -5.1% | +1.1% | +19.8% | +11.5% | -59.7% | |
| – | -5.1% | +0.8% | -2.5% | +6.5% | -0.5% | +8.5% | +17.4% | -12.9% | +14.4% | +12.4% | +15.2% | |
| – | +36.8% | +15.6% | +1.8% | +2.9% | -5.7% | -5.5% | -16.4% | +25.2% | -17.4% | -8.1% | +47.1% | |
| – | +2.2% | +15.1% | +3.5% | +6.7% | -7.4% | -2.1% | -5.2% | +17.5% | +104.5% | +9.7% | -12.7% | |
| – | +42.8% | +14.9% | +4.7% | -0.5% | -4.3% | -11.0% | -17.6% | +9.6% | +6.9% | -41.3% | +94.7% | |
| – | +143.3% | +38.7% | +428.7% | -84.9% | +12.6% | -32.9% | -7.0% | -1.7% | +43.3% | -54.4% | +143.7% | |
| – | +34.5% | +11.3% | -74.4% | +324.2% | -6.6% | -7.4% | -18.9% | +11.2% | +2.5% | -39.1% | +88.5% | |
| – | +27.8% | +12.0% | +2.6% | +0.2% | -1.9% | +2.9% | -13.1% | +7.7% | -35.1% | +69.1% | +26.5% |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.